Regina E. Groves, Director at AtriCure, Inc. (ATRC), bought 1,000 shares at $17.43 ($17K) on 2018-03-01, disclosed to the SEC on 2018-03-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ATRC | BUY | 2021-10-29 | $3K | — | Filing → |
| ATRC | SELL | 2021-09-17 | $472K | — | Filing → |
| ATRC | SELL | 2021-05-28 | $606K | — | Filing → |